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GLOSSARY OF SPECIALIST MEDICAL TERMS FOR LAY PERSON 
 Acute effects – side effects of radiotherapy that occur during treatment delivery or 
up to 3 months post treatment . These effects are dominated by acute inflammation. 
 Adjuvant treatment – a treatment that assists the main treatment in eradicating 
cancer. Often it assists the definitive or main treatment e.g. chemoradiotherapy – the 
chemotherapy makes the radiation more effective.  
 Axilla – anatomical term for region of the armpit. 
 Cancer– a condition whereby cells divide uncontrollably, forming malignant 
tumours that can invade into other parts of the body. 
 Chart – record of patient medical history. 
 Definitive treatment – the main treatment being used to eradicate cancer. Adjuvant 
treatments assist the definitive treatment.  
 Immunosuppression–a condition with decreased immunity. This is associated with 
increased skin cancer risk in older Caucasians living in climates of high ultra violet 
(UV) exposure. 
 Late effects – side effects of radiotherapy that occur at least 6 months after treatment 
delivery. These effects are dominated by chronic inflammation with the laying down 
of fibrosis and consequent loss of organ elasticity. 
 Megavoltage radiotherapy – radiation for treatment produced by linear accelerators 
capable of high generating voltages. The possibility of skin sparing is common with 
this modality. 
 Melanoma – type of skin cancer that metastasizes early. 
 Metastasis– or secondary; cancer that has spread from the primary and is not 
continuous with primary. 
 Multidisciplinary care – when more than one modality or craft group is employed in 
treatment , e.g. surgery and radiotherapy.  
 Non-melanoma skin cancer – skin cancer that is not melanoma. These include basal 
cell or cutaneous squamous cell carcinoma. Other more uncommon non-melanoma 
skin cancers are primary skin lymphomas and merkel cell carcinoma. 




 Palliative treatment – treatment that aims to increase quality rather than quantity of 
life. This treatment is usually given for the relief of a specific cancer symptom e.g. 
pain.  
 Primary – the original cancer from which metastases or secondaries arise. 
 Radical treatment – when the treatment intent is cure or at least increasing survival. 
Treatment side effects are tolerated for this end. 
 Radiobiology– the study of the action of ionizing radiation on living things. 
 Radiotherapy – ionizing electromagnetic energy used in medicine for treating 
pathology, usually cancer.  
 Secondary – or metastases – cancer that has spread from the primary and is not 
continuous with primary. 
 Skin cancer– cancers that have their origin in the epidermis and dermis of skin, the 
visible covering of the body. 
 Skin sparing –property of megavoltage radiation that means that the maximum dose 
is not at the skin surface. 
 Supraorbital – anatomical term for region above the eye. 
 Synergistic treatments – when the combination of both treatments gives more 
tumour control that when the same treatments are used individually.  
 Therapeutic ratio – ratio of tumour cell kill to normal tissue side effects. The aim of 
all cancer treatment is to maximize this ratio – more tumour kill for less normal 
tissue toxicity.  
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The main purpose of the thesis is to highlight the important role that radiotherapy has in 
the treatment of skin cancer. This is critically important in Australia which has the 
highest burden of skin cancer in the world. Twenty four projects were selected from the 
total works of the candidate, the majority being first in world reports. The projects are 
groupedaccording to whether their advances are in the molecular area, are a radiation 
technique, are advances in the clinical area, in quality assurance or guidelines area. 
Most projects owe their origin to astute observation of unexpected findings in the clinic. 
Project quality is high as measured by citations, Impact Factor of the journals in which 
they are published and inclusion in the ERA 2012 Journal List. These projects were 
either practice changing or confirming in their time. As the thesis develops there is a 
growing momentum of the underlying importance of the need for communication, for 
personalized treatment of skin cancer with radiotherapy and for clinical vigilance. This 








The main purpose of the thesis is to highlight the important role that radiotherapy has in 
the treatment of skin cancer. This is critically important in Australia which has the 
highest burden of skin cancer in the world.  
Methodology 
Twenty four projects that led to publication over a ten year period by the candidate were 
selected. They were selected because they were on the subject of radiotherapy of skin 
cancer and represented a new advance.  An essay was written linking them together so 
as to highlight the findings of each individual project and to investigate and discover 
common underlying themes.  
Results 
The quality of the projects is high as they have been published in peer reviewed journals 
with respectable impact factors. A number have been significantly cited in subsequent 
articles and open access publications have received significant hits. Most have been 
published in journals on the ERA 2012 Journal List.  
 
The specific reasons why each project was investigated included: 
 the desire for self audit 
 to find an association 
 to investigate unexpected findings 
 to create much needed guidelines 
 to compare treatments and techniques.  
 
The specific reasons for publishing included: 
 to inform on unexpected results 
 to inform on expected but never before published results 
 to suggest new guidelines 
 to disseminate knowledge on new techniques 
 to invite collaboration in a specific trial 




The linking essay comprises six chapters that deals with advances: 
 on the molecular level 
 in radiation techniques 
 in clinical areas 
 in quality assurance  
 that suggest new guidelines 
 
Significant underlying themes found were: 
 the need for communication 
 the need for personalized treatment of skin cancer with radiotherapy 
 the importance of clinical vigilance.  
 
Conclusions 
This thesis shows that radiotherapy in skin cancer has a real place. It describes 
specifically how the selected projects led to significant advances in the radiation 
treatment of skin. The thesis provides a significant resource for future health workers. It 
also provides a platform for further radiotherapy research into improving skin cancer 
patient outcomes. This thesis will hopefully be a stimulus to other Australian radiation 







This thesis is about advances in radiotherapy in skin cancer. The main purpose of the 
thesis is to highlight the important role that radiotherapy has in the treatment of skin 
cancer. This is critically important in Australia which has the highest burden of skin 
cancer in the world.  
 
There are two main components for assessment in this thesis. The first and major 
component is made up of projects that have led to peer-reviewed publications.  
Significant work occurred during the candidature. The second component is a reflection 
on these advances. This reflection is in the form of a linking essay that introduces and 
integrates the projects. The reflection comments on the advances in the radiation 
treatment of skin cancerinvestigated and published by the candidate in the last ten years.  
 
Twenty four projects were selected from the total published works of the candidate. The 
majority are first in world literature reports aiding their successful passage through peer 
review. These projects were either practice changing or confirming, in their time.  
These projects were selected according to the following criteria: 
a. They are relevant to the radiation treatment of patients with skin cancer.  
b. They represent an advance in skin cancer treatment – they are either a new 
discovery or new way of integrating current technology in the skin cancer 
setting.  
c. They have been deemed worthy of publication by peers so that this information 
may be made available to other physicians involved in the care of skin cancer 
patients 
 
All the projects attempted to enhance the therapeutic ratio of treatment for the benefit of 
patients in the present and of the future. Most projects owe their origin to astute 
observation of unexpected findings in the clinic. The projects were usually initiated by 
the candidate. The specific reasons why each project was investigated included the 
desire for self audit, to find an association, to investigate unexpected findings, to create 
much needed guidelines and to compare treatments and techniques. The specific reasons 
for publishing included: to inform on unexpected results, to inform on expected but 
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never before published results, to suggest new guidelines, to disseminate knowledge on 
new techniques, to invite collaboration in a specific trial and as part of a 
controversy.The quality of the projects is high as they have been published in a peer 
reviewed journals. A number have been significantly cited in subsequent articles and 
open access publications have received significant hits. Most have been published in 
journals on the ERA 2012 Journal List, which have respectable Impact Factors. 
 
The sevenchapters of the thesis include as chapter one an introduction that sets out the 
purpose of the thesis and sets the scene by a focused literature review. The basis of 
radiation is explained, especially the ability to conserve in-field normal tissue. The 
therapeutic ratio has been shown to be a useful tool to evaluate advances. 
 
Chapters two to five describe the contribution to the thesis of projects according to 
whether their advances are in the molecular area, are radiation techniques, are advances 
in the clinical area or the quality assurance and guidelines area. This classification is 
arbitrary but does reflect where the projects impact clinical practice. Chapter six 
outlines significant ongoing projects that occurred during the candidate’s doctoral 
candidature and concern a randomized trial for Whole Brain Radiotherapy (WBRT) in 
melanoma and the provision of cutting edge modern technology to the radiotherapy care 
of skin patients.  
 
 
Chapter two focuses on the molecular basis of radiation for skin cancer. Molecular 
changes are the most fundamental in any living system and determine the outcome at 
more macroscopic levels. The first project (2.1) shows it is necessary to confirm the 
existence of the target in the cells requiring treatment before embarking on a full study 
of a targeted cancer agent in skin cancer. The second study (2.2) found that the 
difference in frequency of alleles encoding a ‘Red Hair Colour’ (RHC) phenotype in the 
cohort of patients with unexpectedly severe acute skin radiation reactions (n=12) was 
significantly increased compared to the control population (p=0.003) and was especially 
associated with the R160W variant allele [odds ratio =3.64 (95% CI:1.3-10.27)]. This 
discovery could potentially contribute to a predictive assay for normal tissue damage 
from RT. The third project (2.3) may have been the first description of a new tumour 
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suppressor gene syndrome with multiple BCCs in previously irradiated fields, multiple 
cancers and multiple immunological disorders in the same patient. These projects were 
all world first reports.  
 
Chapter three comprises techniques developed in an era of three dimensional conformal 
radiotherapy (3DCRT). They all lead to greater conformality of the radiation dose cloud 
to the target, often by use of lateral thinking. The axilla project (3.1) shows that fields 
applied with no knowledge of where the tumour is, and what dose to use, leads to poor 
outcomes. The second project (3.2) shows that new technology is not always necessary 
for better conformality. What is needed is to know the volume requiring radiation and 
the limits of the current tools. The third project (3.3) details how two eyes were saved 
by thinking laterally about eye position during definitive radiotherapy for skin cancer in 
cooperative patients. The last three projects (3.4-3.6) detail techniques written with 
radiation therapists from other countries in mind. These projects were all world first 
reports except the second which was a reply to a previous publication, creating a 
controversy.  
 
Chapterfour comprises projects relating to clinical advances and these are among the 
most frequently cited in the thesis. The chapter has two parts. The first is about imaging 
and comprises three projects about staging. From a study of 100 melanoma patients 
(4.1.1),  it was found that staging magnetic resonance imaging (MRI) brain was only 
needed if patients already had Stage IV disease, had symptoms that may have come 
from a cerebral secondary, or were contemplating significant treatments for which the 
finding of an incidental brain metastasis would have made that treatment inappropriate. 
The next project (4.1.2) showed that astute thinking resulted in finding that a PET scan, 
which diagnosed a melanoma patient as having stage IV disease, actually had a 
warthin’s tumour causing a false positive. The last imaging study (4.1.3) found that PET 
does not add significantly to finding occult primary tumours in 21 cases of patients who 
presented with cervicallymphadenopathyoverthat given by careful clinical, endoscopic, 
and radiological examinations. All these projects show that imaging is helpful but not a 
replacement of the basic clinical skills of proper history taking and examination.   
 
The second part of this chapter consists of projects that examine the interaction of other 
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anti-cancer treatments with radiotherapy. The initial three projects were about 
interactions with surgery. The first project (4.2.1) describes a case of complete reversal 
of neurological symptoms following haemorrhage into a cerebral melanoma metastasis 
with palliative surgery rather than immediate WBRT. The second project (4.2.2) found 
that a delay in postoperative radiotherapy (PORT) for cSCC, BCC and MCC was 
associated with a worse outcome in ten of 330 patients who had to wait longer than our 
unit benchmarks. The third project (4.2.3) describes what can happen when PORT is not 
offered for a positive perineural deep margin following resection of a large BCC of the 
back.  The patient developed spinal cord compression that was salvaged by RT. The last 
two projects concern chemotherapy. The first project (4.2.4) describes activation and 
rapid progression of cSCC in three Caucasians, with long histories of sun damaged skin, 
following administration of Rituximab. The second project (4.2.5) was the third case 
report in the world literature of a radiation recall reaction with Gemcitabine and the first 
about radiation recall myositis. The key point of this chapter is that clinicians need to 
know the relevant place of each diagnostic and therapeutic modality and cannot be just 
an isolated expert in their own.  
 
Chapter five examines quality assurance (QA) issues and guidelines of radiation 
treatments for skin cancer.  Three QA projects are about the QA of treatment process. 
The first (5.1) is an audit of a chart round review which showed that completion rate of 
items that were regarded as necessary for effective treatment increased from 80 to 99% 
with the institution of the chart round. The second project (5.2) details a similar audit of 
a chart round review in a skin radiotherapy unit. The third project (5.3) is an invited 
review of the importance of peer review in QA in the first edition of an international 
textbook; the candidate was the only Australian contributor. Two projects were 
presented under guidelines. Guidelines are produced by recognized experts. They are a 
summary of experience from providers of new advances to new providers of those 
advances. In project 5.4 the candidate assisted with the updating of the National 
Guidelines as the evidence-based consensus for skin cancer radiation practice in 
Australia. Project 5.5 clarified to referrers when referral of a skin cancer patient to a 
skin multidisciplinary clinic which included radiotherapists was appropriate. Studying 
how advances are applied through QA completes the journey from idea to safe routine 
clinical practice.  The development of guidelines then makes these advances available 
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for new practitioners in other departments to apply them safely and in a standard and 
comparable fashion, an important consideration for dissemination of new advances 
throughout the industry and for standardization in collaborative ongoing multicenter 
research.  
 
Chapter six outlines projects that occurred during the candidate’s doctoral candidature 
and are ongoing.  Project 6.1 will provide evidence for WBRT in melanoma. At this 
stage WBRT is given or withheld in melanoma on the basis of no specific randomized 
evidence. Project 6.2 will strengthen the case to provide cutting edge modern 
technology to the radiotherapy care of skin patients.  
 
Chapter seven summarises and concludes the thesis, and gives direction for further 
research.  
 
Recurring themes throughout of the thesis have been:  
 1. The need for communication within and without the multidisciplinary team.  
 2. The need for personalized treatment of skin cancer with radiotherapy, given the 
great variety of patient, tumour and treatment factors. 
 3. The importance of clinical vigilance.  
The contributions of the projects to these themes have been commented on in each 
chapter. There has been a growing momentum of the underlying importance of these 
themes in the radiotherapy care of patients with skin cancer as the thesis develops. 
 
This thesis provides a significant resource to health workers involved in the radiation 
treatment of patients with skin cancer. It also provides a platform for further research 
into improving skin cancer patient outcomes. It shows that radiotherapy in skin cancer 
has a real place and this thesis will be a stimulus to other Australian radiation 
oncologists to engage in this important subspecialty. As Australia has the highest 
incidence of skin cancer in the world, spends the majority of its cancer budget on skin 
cancer and has rising incidence and mortality from this group of diseases, it is only 
fitting that Australia plays a leading role in advancing the radiation treatments available 
for skin cancer.   
